Novel SPECC1L-MET Fusion Detected in Circulating Tumor DNA in a Patient with Lung Adenocarcinoma following Treatment with Erlotinib and Osimertinib

被引：23
作者：
Nelson, Annie W. [1 ]
Schrock, Alexa B. [1 ]
Pavlick, Dean C. [1 ]
Ali, Siraj M. [1 ]
Atkinson, Emily C. [2 ]
Chachoua, Abraham [3 ]
机构：
[1] Fdn Med Inc, Cambridge, MA USA
[2] NYU, Dept Med, Langone Med Ctr, 550 1St Ave, New York, NY 10016 USA
[3] NYU, Laura & Isaac Perlmutter Canc Ctr, Langone Hlth, New York, NY USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2019年 / 14卷 / 02期
关键词：
D O I：
10.1016/j.jtho.2018.10.160
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：E27 / E29
页数：4
相关论文
共 5 条
  • [1] Acquired resistance to TKIs in solid tumours: learning from lung cancer
    Camidge, D. Ross
    Pao, William
    Sequist, Lecia V.
    [J]. NATURE REVIEWS CLINICAL ONCOLOGY, 2014, 11 (08) : 473 - 481
  • [2] Analytical Validation of a Hybrid Capture-Based Next-Generation Sequencing Clinical Assay for Genomic Profiling of Cell-Free Circulating Tumor DNA
    Clark, Travis A.
    Chung, Jon H.
    Kennedy, Mark
    Hughes, Jason D.
    Chennagiri, Niru
    Lieber, Daniel S.
    Fendler, Bernard
    Young, Lauren
    Zhao, Mandy
    Coyne, Michael
    Breese, Virginia
    Young, Geneva
    Donahue, Amy
    Pavlick, Dean
    Tsiros, Alyssa
    Brennan, Timothy
    Zhong, Shan
    Mughal, Tariq
    Bailey, Mark
    He, Jie
    Roels, Steven
    Frampton, Garrett M.
    Spoerke, Jill M.
    Gendreau, Steven
    Lackner, Mark
    Schleifman, Erica
    Peters, Eric
    Ross, Jeffrey S.
    Ali, Siraj M.
    Miller, Vincent A.
    Gregg, Jeffrey P.
    Stephens, Philip J.
    Welsh, Allison
    Otto, Geoff A.
    Lipson, Doron
    [J]. JOURNAL OF MOLECULAR DIAGNOSTICS, 2018, 20 (05) : 686 - 702
  • [3] Structural Alterations of MET Trigger Response to MET Kinase Inhibition in Lung Adenocarcinoma Patients
    Plenker, Dennis
    Bertrand, Miriam
    de Langen, Adrianus J.
    Riedel, Richard
    Lorenz, Carina
    Scheel, Andreas H.
    Mueller, Judith
    Braegelmann, Johannes
    Dassler-Plenker, Juliane
    Kobe, Carsten
    Persigehl, Thorsten
    Kluge, Alexander
    Wurdinger, Thomas
    Schellen, Pepijn
    Hartmann, Gunther
    Zacherle, Tobias
    Menon, Roopika
    Thunnissen, Erik
    Buettner, Reinhard
    Griesinger, Frank
    Wolf, Juergen
    Heukamp, Lukas
    Sos, Martin L.
    Heuckmann, Johannes M.
    [J]. CLINICAL CANCER RESEARCH, 2018, 24 (06) : 1337 - 1343
  • [4] Receptor Tyrosine Kinase Fusions and BRAF Kinase Fusions are Rare but Actionable Resistance Mechanisms to EGFR Tyrosine Kinase Inhibitors
    Schrock, Alexa B.
    Zhu, Viola W.
    Hsieh, Wen-Son
    Madison, Russell
    Creelan, Benjamin
    Silberberg, Jeffrey
    Costin, Dan
    Bharne, Anjali
    Bonta, Ioana
    Bosemani, Thangavijayan
    Nikolinakos, Petros
    Ross, Jeffrey S.
    Miller, Vincent A.
    Ali, Siraj M.
    Klempner, Samuel J.
    Ou, Sai-Hong Ignatius
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (09) : 1312 - 1323
  • [5] The landscape of kinase fusions in cancer
    Stransky, Nicolas
    Cerami, Ethan
    Schalm, Stefanie
    Kim, Joseph L.
    Lengauer, Christoph
    [J]. NATURE COMMUNICATIONS, 2014, 5
1